Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment
Bringing the medicine access fight to the US
Beyond “Capacity Building”: Crafting Partnerships Based on Equality
Public Participation in the Patent System Will Lower Drug Costs
How High-Priced Drugs Cripple Prison Health Care—and Reform
Patent abuse is driving up drug prices. Just look at Lantus
Wall Street Wants the Best Patents, Not the Best Drugs
Pharma patent owners in the US are under pressure like they have never been before